ABSTRACT
La fiebre chikungunya (CHIK) es una enfermedad viral transmitida al ser humano por el mismo vector del dengue, el mosquito Aedes. Además de fiebre y fuertes dolores articulares, produce otros síntomas como mialgias, cefalea, náuseas, cansancio y exantema. No tiene tratamiento específico; el manejo terapéutico de los pacientes se enfoca en el alivio de los síntomas. Históricamente se han reportado brotes de grandes proporciones; incluso desde 2010 se llegó a considerar como una potencial epidemia emergente. En 2013 se introdujo a las islas del Caribe y recientemente se ha reportado en el continente americano. En este trabajo se describe el primer caso confirmado de chikungunya en México, en el municipio de Tlajomulco de Zúñiga, Jalisco, en mayo de 2014, importado de la isla Antigua y Barbuda, en el Caribe, por una mujer de 39 años de edad.
Chikungunya fever (CHIK) is a viral disease transmitted to human beings by the same vector as dengue -the Aedes mosquito. Besides fever and severe pain in the joints, it produces other symptoms such as myalgias, headache, nausea, fatigue and exanthema. There is no specific treatment for it; the therapeutic management of patients focuses on symptom relief. Historically, outbreaks of large proportions have been reported; even since 2010 it was considered to be a potential emerging epidemic. In 2013 it was introduced into the islands of the Caribbean, and it has recently been reported in the American continent. This paper describes the first confirmed case of chikungunya in Mexico -in the municipality of Tlajomulco de Zúñiga, Jalisco, in May, 2014-, which was imported from the Caribbean island of Antigua and Barbuda by a 39 year-old woman.
Subject(s)
Animals , Cattle , Male , Rats , Antidotes/pharmacology , Hot Temperature , Imidazoles/toxicity , Meat , Mitochondria/metabolism , Mutagens/toxicity , Oxygen Consumption/drug effects , Ubiquinone/pharmacology , Antidotes/administration & dosage , Cooking , Diet , Electron Transport Complex II , Electron Transport Complex III/metabolism , Electron Transport Complex IV/metabolism , Electron Transport/drug effects , Food, Fortified , Mitochondria, Heart/drug effects , Mitochondria, Heart/metabolism , Mitochondria, Liver/drug effects , Mitochondria, Liver/metabolism , Mitochondria, Muscle/drug effects , Mitochondria, Muscle/metabolism , Multienzyme Complexes/metabolism , NAD(P)H Dehydrogenase (Quinone)/metabolism , Oxidoreductases/metabolism , Rats, Wistar , Succinate Dehydrogenase/metabolism , Ubiquinone/administration & dosageABSTRACT
Enzymatic activity was analyzed in the soleus, gastrocnemius (red and white) and plantaris muscles of acutely exercised rats after long-term administration of Panax ginseng extract in order to evaluate the protective role of ginseng against skeletal muscle oxidation. Ginseng extract (3, 10, 100, or 500 mg/kg) was administered orally for three months to male Wistar rats weighing 200 ± 50 g before exercise and to non-exercised rats (N = 8/group). The results showed a membrane stabilizing capacity of the extract since mitochondrial function measured on the basis of citrate synthase and 3-hydroxyacyl-CoA dehydrogenase activities was reduced, on average, by 20 percent (P < 0.05) after exercise but the activities remained unchanged in animals treated with a ginseng dose of 100 mg/kg. Glutathione status did not show significant changes after exercise or treatment. Lipid peroxidation, measured on the basis of malondialdehyde levels, was significantly higher in all muscles after exercise, and again was reduced by about 74 percent (P < 0.05) by the use of ginseng extract. The administration of ginseng extract was able to protect muscle from exercise-induced oxidative stress irrespective of fiber type.
Subject(s)
Animals , Male , Rats , Antioxidants/pharmacology , Lipid Peroxidation/drug effects , Mitochondria, Muscle/drug effects , Muscle, Skeletal/drug effects , Oxidative Stress/drug effects , Physical Conditioning, Animal , Panax/chemistry , /metabolism , Antioxidants/administration & dosage , Citrate (si)-Synthase/metabolism , Glutathione/drug effects , Glutathione/metabolism , Malondialdehyde/analysis , Mitochondria, Muscle/metabolism , Muscle, Skeletal/metabolism , Plant Extracts/pharmacology , Rats, Wistar , Superoxide Dismutase/metabolismABSTRACT
Treatment of bovine pulmonary artery smooth muscle tissue mitochondria with H2O2 stimulated iron release, hydroxyl radical (OH) production and lipid peroxidation. Pretreatment of mitochondria with deferoxamine (DFO) and dimethyl thiourea (DMTU) prevented OH production and markedly reduced lipid peroxidation without appreciably altering iron release caused by H2O2. Simultaneous treatment of either DFO or DMTU with H2O2 significantly reduced lipid peroxidation and also prevented OH production without causing marked decrease in iron release. In contrast, addition of DFO or DMTU even 2 min after treatment of the mitochondria with H2O2 did not significantly altered iron release, OH production and lipid peroxidation. Pretreatment of the mitochondria with 4,4'-dithiocyano-2,2'-disulfonic acid stilbene (DIDS) markedly reduced lipid peroxidation without appreciably altering the increase in OH production and iron release caused by H2O2.
Subject(s)
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid/pharmacology , Animals , Cattle , Deferoxamine/pharmacology , Free Radical Scavengers/pharmacology , Hydrogen Peroxide/pharmacology , Lipid Peroxidation , Mitochondria, Muscle/drug effects , Muscle, Smooth, Vascular/drug effects , Pulmonary Circulation/drug effects , Thiourea/analogs & derivativesABSTRACT
Con el fin de esclarecer los mecanismos bioquímicos involucrados en el establecimiento de la enfermedad hipertensiva inducida por el cadmio, en este trabajo se estudió el efecto del metal sobre diversas funciones mitocondriales, a saber: transporte de calcio y producción de energía. La presencia de cadmio en el medio inhibe ambas funciones debido a la unión de este metal a los grupos sulfhidrilo presentes en las proteínas de las cuales dependen estos procesos. En base a estos resultados es posible proponer un esquema en el cual el cadmio produce de manera directa un efecto de vasoconstricción renal el cual a su vez explica otros mecanismos que aparecen durante la enfermedad hipertensiva